Leukemia-associated Rho guanine nucleotide exchange factor (LARG) plays an agonist specific role in platelet function through RhoA activation

We studied the of LARG in murine and human megakaryocytes and platelets with Larg knockout, shRNA-mediated knockdown and small molecule-mediated inhibition. We found that LARG is important for human, but not murine, megakaryocyte maturation. Larg KO mice exhibit macrothrombocytopenia, internal bleeding in the ovaries and prolonged bleeding times. KO platelets have impaired aggregation, α -granule release and integrin α 2b β 3 activation in response to thrombin and thromboxane, but not to ADP. The same agonist-specific reductions in platelet aggregation occur in human platelets treated with a LARG inhibitor. Larg KO platelets have reduced RhoA activation and myosin light chain phosphorylation, suggesting that Larg plays an agonist-specific role in platelet signal transduction. Using 2 different in vivo assays, Larg KO mice are protected from in vivo thrombus formation. Together, these results establish that LARG regulates human megakaryocyte maturation, and is critical for platelet function in both humans and mice. that LARG deficiency or inhibition would affect thrombin-induced platelet activation by decreasing thrombin-induced RhoA activation. We assessed the role of LARG in platelet function by characterizing the in vitro and in vivo megakaryocyte and platelet phenotypes of Larg KO mice, and by assessing human megakaryocyte (MK) and platelet function in the presence of a LARG inhibitor. Murine MK were assessed in Larg KO mice and human megakaryopoiesis was assessed in vitro using shRNA and inhibitor treatments. We found that LARG is important for human MK maturation, but Larg KO mice had no detectable differences in megakaryopoiesis. However, LARG appears to play a role in activation of both murine and human platelets specifically in response to thrombin and thromboxane via activation of RhoA signaling. Moreover, LARG was shown to play an important role in two in vivo murine thrombosis models, carotid artery ligation and FeCl 3 induced carotid damage.

[1]  S. Offermanns,et al.  Leukemia‐associated Rho guanine‐nucleotide exchange factor is not critical for RhoA regulation, yet is important for platelet activation and thrombosis in mice , 2015, Journal of thrombosis and haemostasis : JTH.

[2]  A. Poole,et al.  Platelet Rho GTPases–a focus on novel players, roles and relationships , 2015, The Biochemical journal.

[3]  Vandana Solanki,et al.  Conservative management of corpus luteum haemorrhage in patients on anticoagulation: a report of three cases and review of literature , 2015, Archives of Gynecology and Obstetrics.

[4]  C. Shaw,et al.  Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. , 2014, Blood.

[5]  Yu Jin,et al.  Aldose Reductase–Mediated Phosphorylation of p53 Leads to Mitochondrial Dysfunction and Damage in Diabetic Platelets , 2014, Circulation.

[6]  O. McCarty,et al.  The PAK system links Rho GTPase signaling to thrombin-mediated platelet activation. , 2013, American journal of physiology. Cell physiology.

[7]  G. Crooks,et al.  Critical Differences in Hematopoiesis and Lymphoid Development between Humans and Mice , 2013, Journal of Clinical Immunology.

[8]  H. Yagi,et al.  PDZ-RhoGEF and LARG Are Essential for Embryonic Development and Provide a Link between Thrombin and LPA Receptors and Rho Activation* , 2013, The Journal of Biological Chemistry.

[9]  Nisha S. Sipes,et al.  Small-molecule inhibitors targeting G-protein–coupled Rho guanine nucleotide exchange factors , 2013, Proceedings of the National Academy of Sciences.

[10]  Y. Tseng,et al.  Angiotensin II regulates the LARG/RhoA/MYPT1 axis in rat vascular smooth muscle in vitro , 2012, Acta Pharmacologica Sinica.

[11]  T. Wieland,et al.  LARG links histamine-H1-receptor-activated Gq to Rho-GTPase-dependent signaling pathways. , 2012, Cellular signalling.

[12]  Shuchi Gupta,et al.  Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis. , 2012, Blood.

[13]  N. Mackman,et al.  Towards a standardization of the murine ferric chloride‐induced carotid arterial thrombosis model , 2011, Journal of thrombosis and haemostasis : JTH.

[14]  S. Morrison,et al.  Human and rhesus macaque hematopoietic stem cells cannot be purified based only on SLAM family markers. , 2011, Blood.

[15]  Xiaoping Du,et al.  Signaling During Platelet Adhesion and Activation , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Aittaleb,et al.  Structure and Function of Heterotrimeric G Protein-Regulated Rho Guanine Nucleotide Exchange Factors , 2010, Molecular Pharmacology.

[17]  V. Vicente,et al.  Platelet receptors and signaling in the dynamics of thrombus formation , 2009, Haematologica.

[18]  S. Kunapuli,et al.  RhoA downstream of G(q) and G(12/13) pathways regulates protease-activated receptor-mediated dense granule release in platelets. , 2009, Biochemical pharmacology.

[19]  M. Vaduganathan,et al.  Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. , 2008, Journal of the American College of Cardiology.

[20]  C. Gachet P2 receptors, platelet function and pharmacological implications , 2008, Thrombosis and Haemostasis.

[21]  K. Akashi,et al.  Hematopoietic developmental pathways: on cellular basis , 2007, Oncogene.

[22]  David Bryder,et al.  Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. , 2007, Cell stem cell.

[23]  G. L. Le Breton,et al.  Signaling through Gα13 Switch Region I Is Essential for Protease-activated Receptor 1-mediated Human Platelet Shape Change, Aggregation, and Secretion* , 2007, Journal of Biological Chemistry.

[24]  N. Hay,et al.  A Phosphoinositide 3-Kinase-AKT-Nitric Oxide-cGMP Signaling Pathway in Stimulating Platelet Secretion and Aggregation* , 2006, Journal of Biological Chemistry.

[25]  Z. Ying,et al.  Angiotensin II Up-Regulates the Leukemia-Associated Rho Guanine Nucleotide Exchange Factor (RhoGEF), a Regulator of G Protein Signaling Domain-Containing RhoGEF, in Vascular Smooth Muscle Cells , 2006, Molecular Pharmacology.

[26]  S. Coughlin,et al.  Protease‐activated receptors in hemostasis, thrombosis and vascular biology , 2005, Journal of thrombosis and haemostasis : JTH.

[27]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[28]  J. Dick,et al.  Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression , 2005, The Journal of experimental medicine.

[29]  D. Siderovski,et al.  The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits , 2005, International journal of biological sciences.

[30]  C. Der,et al.  GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors , 2005, Nature Reviews Molecular Cell Biology.

[31]  M. Birnbaum,et al.  Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. , 2004, The Journal of clinical investigation.

[32]  Anita Preininger,et al.  Insights into G protein structure, function, and regulation. , 2003, Endocrine reviews.

[33]  P. Romeo,et al.  Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein , 2003, Nature Medicine.

[34]  M. Simon,et al.  G13 is an essential mediator of platelet activation in hemostasis and thrombosis , 2003, Nature Medicine.

[35]  L. Brass Thrombin and platelet activation. , 2003, Chest.

[36]  S. Jacobsen,et al.  Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. , 2003, Blood.

[37]  G. Sauvageau,et al.  HOXB4-Induced Expansion of Adult Hematopoietic Stem Cells Ex Vivo , 2002, Cell.

[38]  Z. Galis,et al.  Remodeling of Carotid Artery Is Associated With Increased Expression of Matrix Metalloproteinases in Mouse Blood Flow Cessation Model , 2000, Circulation.

[39]  M. Caligiuri,et al.  Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Kunapuli,et al.  Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Hiromitsu Nakauchi,et al.  Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell , 1996, Science.

[42]  M. Terzic,et al.  Conservative management of massive hematoperitoneum caused by ovulation in a patient with severe form of von Willebrand disease--a case report. , 2012, Clinical and experimental obstetrics & gynecology.

[43]  B. Nieswandt,et al.  Unresponsiveness of platelets lacking both Galpha(q) and Galpha(13). Implications for collagen-induced platelet activation. , 2004, The Journal of biological chemistry.

[44]  B. Nieswandt,et al.  Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets. , 2002, The Journal of biological chemistry.

[45]  C. Der,et al.  Leukemia-associated Rho guanine nucleotide exchange factor promotes G alpha q-coupled activation of RhoA. , 2002, Molecular and Cellular Biology.

[46]  M. Simon,et al.  Defective platelet activation in G alpha(q)-deficient mice. , 1997, Nature.